|
Synonyms: Intron A® | intronA
IFN-α2b (recombinant human) is an approved drug (FDA (1986))
Compound class:
Peptide
Comment: The sequence of IFN-α2b, differs in only one residue from the sequence of the endogenous peptide, with Lys23 being replaced by Arg.
|
For advanced searching click here to open chemical structure editor
Other Similar Sequences  |
|
| IFN-α1/13 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α10 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α14 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α16 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α17 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α2 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α21 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α4 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α5 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α6 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α7 {Sp: Human} |
TargetsInterferon-α/β receptor |
| IFN-α8 {Sp: Human} |
TargetsInterferon-α/β receptor |
| peginterferon alfa-2b |
TargetsInterferon-α/β receptor; interferon α/β receptor 1 |
